Among the 62 enrolled patients with laboratory‐confirmed MERS, 15 patients (24.2%) were positive for immunoglobulin G auto‐Abs for at least one subtype of type I IFNs, including IFN‐α2, IFN‐β, and/or IFN‐ω (Figure 1). The gene discussed is IFNA2; the disease is Middle East respiratory syndrome.